致病性拉敏A突变的精确基因编辑可以纠正心脏病
Xurde M Caravia1,2, Brian Hayashi1,2, Hui Li1,2
1Department of Molecular Biology, Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
概括
精确的基因编辑 (BE) 纠正了Lamin A (LMNA) 基因中引起疾病的突变,在细胞和小鼠模型中有效治疗了拉米诺病. 这种基因治疗方法对未来的人类治疗有希望.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 心脏病学 心脏病学
- 神经肌肉疾病 神经肌肉疾病
背景情况:
- 拉米诺病是一种严重的遗传性疾病,由拉米纳A (LMNA) 基因突变引起,通常缺乏有效的治疗方法.
- 特定的LMNA突变L35P和R249Q分别导致先天性肌肉发育不良 (CMD) 和带有导电缺陷的扩张性心肌病 (DCM-CD).
- 现有的细胞和动物模型表现出显著的病理表型,反映了人类疾病.
研究的目的:
- 开发和评估精确的基编辑 (BE) 策略,以纠正致病性LMNA基因变异.
- 评估基准编辑在拉米诺病的疾病模型中的治疗效果.
- 研究基准编辑作为LMNA相关心脏和肌肉疾病的潜在治疗方法.
主要方法:
- 开发用于R249Q的腺基编辑 (ABE) 和用于L35PLMNA突变的细胞基编辑 (CBE).
- 利用诱导多能干细胞衍生心肌细胞 (iPSC-CMs) 和携带LMNA突变的人性化小鼠模型.
- 亚地诺相关病毒 (AAV) 载体被用于基编辑组件的体内传递.
主要成果:
- 基编辑纠正了iPSC-CM中的LMNA突变,在体外拯救了细胞异常,如核异常和DNA损伤.
- 在人性化的小鼠模型中,以AAV为媒介的基调编辑可以预防病态表型,包括心脏功能障碍和肌肉损耗,并延长寿命.
- ABE和CBE策略在纠正致病性LMNA变体和改善疾病表现方面表现出高效.
结论:
- 精确的基因编辑是纠正致病LMNA突变的高效策略.
- 基调编辑疗法成功地在细胞和体内模型中拯救了表型.
- 这项研究确立了基调编辑作为治疗人类层状病变的有希望的治疗途径.
相关概念视频
Mutations
Overview
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Genome Copying Errors
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...


